Lucas, Carolina http://orcid.org/0000-0003-4590-2756
Vogels, Chantal B. F.
Yildirim, Inci
Rothman, Jessica E. http://orcid.org/0000-0002-9961-1092
Lu, Peiwen http://orcid.org/0000-0001-6118-872X
Monteiro, Valter
Gehlhausen, Jeff R.
Campbell, Melissa
Silva, Julio http://orcid.org/0000-0001-8212-7440
Tabachnikova, Alexandra
Peña-Hernandez, Mario A.
Muenker, M. Catherine http://orcid.org/0000-0002-0450-0868
Breban, Mallery I. http://orcid.org/0000-0002-8976-9988
Fauver, Joseph R. http://orcid.org/0000-0001-8099-2991
Mohanty, Subhasis
Huang, Jiefang
,
Pearson, Claire
Muyombwe, Anthony
Downing, Randy
Razeq, Jafar
Petrone, Mary
Ott, Isabel
Watkins, Anne
Kalinich, Chaney
Alpert, Tara
Brito, Anderson
Earnest, Rebecca
Murphy, Steven
Neal, Caleb
Laszlo, Eva
Altajar, Ahmad
Tikhonova, Irina
Castaldi, Christopher
Mane, Shrikant
Bilguvar, Kaya
Kerantzas, Nicholas
Ferguson, David
Schulz, Wade
Landry, Marie
Peaper, David
Shaw, Albert C.
Ko, Albert I. http://orcid.org/0000-0001-9023-2339
Omer, Saad B. http://orcid.org/0000-0002-5383-3474
Grubaugh, Nathan D.
Iwasaki, Akiko http://orcid.org/0000-0002-7824-9856
Article History
Received: 10 July 2021
Accepted: 30 September 2021
First Online: 11 October 2021
Competing interests
: A.I. served as a consultant for Spring Discovery, Boehringer Ingelheim and Adaptive Biotechnologies. I.Y. reported being a member of the mRNA-1273 Study Group and has received funding to her institution to conduct clinical research from BioFire, MedImmune, Regeneron, PaxVax, Pfizer, GSK, Merck, Novavax, Sanofi-Pasteur and Micron. N.D.G. is a consultant for Tempus Labs to develop infectious disease diagnostic assays. All other authors declare no competing interests.
Free to read: This content has been made available to all.